FIELD: medicine, endocrinology, therapy, pharmacy. SUBSTANCE: invention relates to treatment of states associated with obesity. Invention proposes to use the combined effect of sibutramine and orlistat, in particular, as a pharmaceutical composition. Invention provides additional synergetic effect in treatment in attainment of the constant value of body mass loss and reducing adverse effect of therapy. EFFECT: valuable medicinal properties of treatment and composition. 4 cl, 2 tbl
Authors
Dates
2004-05-27—Published
2000-06-16—Filed